Periodontitis affects glucoregulatory hormones in severely obese individuals

[1]  A. Flyvbjerg,et al.  Comorbidity of periodontal disease: two sides of the same coin? An introduction for the clinician , 2017, Journal of oral microbiology.

[2]  T. Hirano,et al.  Anti‐atherogenic and anti‐inflammatory properties of glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypepide, and dipeptidyl peptidase‐4 inhibitors in experimental animals , 2016, Journal of diabetes investigation.

[3]  N. Marx,et al.  Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism , 2016, Cardiovascular Diabetology.

[4]  P. Preshaw,et al.  Detection and diagnosis of periodontal conditions amenable to prevention , 2015, BMC Oral Health.

[5]  A. Åstrøm,et al.  Influence of type 2 diabetes on local production of inflammatory molecules in adults with and without chronic periodontitis: a cross-sectional study , 2015, BMC oral health.

[6]  B. Mealey,et al.  American Academy of Periodontology Task Force Report on the Update to the 1999 Classification of Periodontal Diseases and Conditions. , 2015, Journal of periodontology.

[7]  B. Heitmann,et al.  The Association Between Periodontal Disease and Overweight and Obesity : A Systematic Review , 2015 .

[8]  A. Pfeiffer,et al.  GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial , 2015, Diabetologia.

[9]  A. Åstrøm,et al.  Impact of Chronic Periodontitis on Levels of Glucoregulatory Biomarkers in Gingival Crevicular Fluid of Adults with and without Type 2 Diabetes , 2015, PloS one.

[10]  F. Tacke,et al.  GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6–Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering , 2014, Diabetes.

[11]  D. Drucker,et al.  Lipopolysaccharides-Mediated Increase in Glucose-Stimulated Insulin Secretion: Involvement of the GLP-1 Pathway , 2014, Diabetes.

[12]  S. Khalili,et al.  Tumor Necrosis Factor-α and Interleukin-6: Potential Interorgan Inflammatory Mediators Contributing to Destructive Periodontal Disease in Obesity or Metabolic Syndrome , 2013, Mediators of inflammation.

[13]  J. Holst,et al.  Glucose-Dependent Insulinotropic Polypeptide , 2011, Diabetes.

[14]  J. Holst,et al.  Glucose-Dependent Insulinotropic Polypeptide A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans , 2011 .

[15]  M. Gabriele,et al.  Systemic inflammation following non-surgical and surgical periodontal therapy. , 2010, Journal of clinical periodontology.

[16]  J. Ruidavets,et al.  Metabolic syndrome, insulin resistance, and periodontitis: a cross-sectional study in a middle-aged French population. , 2010, Journal of clinical periodontology.

[17]  P. Halban,et al.  Interleukin-6 regulates pancreatic α-cell mass expansion , 2008, Proceedings of the National Academy of Sciences.

[18]  A. Golay,et al.  Association of fasting glucagon and proinsulin concentrations with insulin resistance , 2007, Diabetologia.

[19]  N Claffey,et al.  Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. Group C consensus report of the 5th European Workshop in Periodontology. , 2005, Journal of clinical periodontology.